<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729349</url>
  </required_header>
  <id_info>
    <org_study_id>CR108555</org_study_id>
    <secondary_id>CNTO148ARA4010</secondary_id>
    <nct_id>NCT03729349</nct_id>
  </id_info>
  <brief_title>Golimumab for Adherence in Rheumatoid Arthritis</brief_title>
  <acronym>GO FAR</acronym>
  <official_title>Golimumab for Adherence in Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Janssen Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Janssen Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs
      in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is
      associated with a greater incidence of disease in clinical practice.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Anticipated">December 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of Adherence on Flares as Assessed by Rheumatoid Arthritis Flare Questionnaire (RA-FQ) Score at 6 Month</measure>
    <time_frame>6 Month</time_frame>
    <description>Impact of adherence on flares will be assessed by RA-FQ score or the answer to question 7 of the RA-FQ (Are you having a flare?) at 6 month in participants categorized as &quot;low predicted compliance&quot; vs &quot;high predicted compliance&quot;. RA-FQ is 10 point scale for questions 1 to 5, with score range from 0 to 10, where higher score indicates worse outcome and having option 'Yes' and 'No' for question 6 and 7. The RA-FQ total score is calculated as the sum of responses for items 1-5 (maximum 50). Higher score indicates worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of Adherence on Flares as Assessed by RA-FQ Score at 12 Month</measure>
    <time_frame>12 Month</time_frame>
    <description>Impact of adherence on flares will be assessed by RA-FQ score or the answer to question 7 of the RA-FQ (Are you having a flare?) at 12 month in participants categorized as &quot;low predicted compliance&quot; vs &quot;high predicted compliance&quot;. RA-FQ is 10 point scale for questions 1 to 5, with score range from 0 to 10, where higher score indicates worse outcome and having option 'Yes' and 'No' for question 6 and 7. The RA-FQ total score is calculated as the sum of responses for items 1-5 (maximum 50). Higher score indicates worst outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Adherent Participants at 6 and 12 Months</measure>
    <time_frame>Months 6 and 12</time_frame>
    <description>Percentage of adherent participants at 6 and 12 Months will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Corticosteroid Use</measure>
    <time_frame>Months 6 and 12</time_frame>
    <description>Number of participants with corticosteroid use will be assessed among participants categorized as &quot;low predicted compliance&quot; vs &quot;high predicted compliance&quot; at 6 and 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predicting Factors for Adherence</measure>
    <time_frame>Months 6 and 12</time_frame>
    <description>Independent predictors of &quot;predicted compliance&quot; will be assessed with univariate and multivariate Cox regression analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with any Adverse Events (AEs), Serious Adverse Events (SAEs) or Discontinuation of Golimumab</measure>
    <time_frame>Months 6 and 12</time_frame>
    <description>Number of participants with any AEs, SAEs or discontinuation of golimumab will be assessed among participants categorized as &quot;low predicted compliance&quot; vs &quot;high predicted compliance&quot; at 6 and 12 months and include any such event up to the previous study visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with Response to Patient Support Program Question</measure>
    <time_frame>Months 6 and 12</time_frame>
    <description>Percentage of participants with response to Patient Support Program Question (Yes/No) will be assessed among participants categorized as &quot;low predicted compliance&quot; vs &quot;high predicted compliance&quot; at 6 and 12 months.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <arm_group>
    <arm_group_label>Participants with Diagnosis of Rheumatoid Arthritis</arm_group_label>
    <description>Participants will not receive any intervention as a part of this study. All Rheumatoid Arthritis (RA) participants treated with golimumab in a clinical practice setting will be observed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Golimumab</intervention_name>
    <description>Participants will receive golimumab as a part of clinical practice.</description>
    <arm_group_label>Participants with Diagnosis of Rheumatoid Arthritis</arm_group_label>
    <other_name>SIMPONI ™</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All Rheumatoid Arthritis (RA) participants treated with golimumab in a clinical practice
        setting will be observed.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must have a confirmed diagnosis of rheumatoid arthritis

          -  About to initiate therapy with golimumab

          -  Must sign a participation agreement/informed consent form (ICF) allowing data
             collection and source data verification in accordance with local requirements

        Exclusion Criteria:

          -  Diagnosis of Axial Spondyloarthritis, Ankylosing Spondylitis or Psoriatic Arthritis

          -  Received an investigational drug (including investigational vaccines) or used an
             invasive investigational medical device within 90 days before the start of the study
             or the first data collection time point

          -  Currently enrolled in an investigational study

          -  Currently enrolled in an observational study sponsored or managed by a Janssen company
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janssen Inc. Clinical Trial</last_name>
    <role>Study Director</role>
    <affiliation>Janssen Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Contact</last_name>
    <phone>844-434-4210</phone>
    <email>JNJ.CT@sylogent.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jacqueline C Stewart Medical Inc.</name>
      <address>
        <city>Penticton</city>
        <state>British Columbia</state>
        <zip>V2A 3G7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Milton F Baker Inc.</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8P 5P6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fredericton Medical Clinic</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <zip>E3B 6H5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nexus Clinical Research</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1A 5E8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Clare's Hospital</name>
      <address>
        <city>St. John's</city>
        <state>NFLD</state>
        <zip>A1C 2E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Private Practice - Dr. Diane Wilson</name>
      <address>
        <city>Lunenburg</city>
        <state>Nova Scotia</state>
        <zip>B0J2C0</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Waterside Clinic</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <zip>L4M 6L2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Sankalp V. Bhavsar Medicine Professional Corporation</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7R 2H3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Private Practice - Dr. Pauline Boulos</name>
      <address>
        <city>Dundas</city>
        <state>Ontario</state>
        <zip>L9H 1B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Sangeetha Thiviyarajah Medicine Professional Corporation</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9V 3Z7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samuel Silverberg Medicine Professional Corporation</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9V 5G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Adachi Medicine Professional Corporation</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Manisha Mulgund Medicine Professional Corporation</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L9C 5N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>K-W Musculoskeletal Research Inc</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2M 5N6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Thanu Ruban Medicine Professional Corporation</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>M1C 3S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Credit Valley Rheumatology</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2V8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Rajwinder S Dhillon Medicine Professional Corporation</name>
      <address>
        <city>Niagara Falls</city>
        <state>Ontario</state>
        <zip>L2E 6A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Makhzoum Medicine Professional Coporation</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6H 3P1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. S. Gill Medicine Professional Corporation</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6M 1M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Abraham Chaiton Medicine Professional Corporation</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3N 2V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Regional Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Arthur Karasik Medicine Professional Corporation</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6C 1Y8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Sabeen Anwar Medicine Professional Corporation</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8X 1T3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique de Rhumatologie de Montreal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4N 1C6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CIUSSS de L'Estrie - CHUS</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1G 2E8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre de Recherche Musculo Squelettique</name>
      <address>
        <city>Trois Rivieres</city>
        <state>Quebec</state>
        <zip>G8Z1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Community Rheumatology Care</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7K 0H6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rheumatology Associates of Saskatoon</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7K 0H6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pierre-Boucher Hospital</name>
      <address>
        <city>Longueuil</city>
        <zip>J4M 2A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Private Practice - Dr. Louis Bessette</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 3M7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre de sante et services sociaux (CSSS) de Rimouski-Neigette - Hopital regional - Rimouski</name>
      <address>
        <city>Rimouski</city>
        <zip>G5L 5T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Jacques Cartier- Rheumatology Division - Université de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <zip>J1J 2E3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://pam.sylogent.com/cr/CR108555</url>
    <description>To learn how to participate in this trial please click here.</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

